Neratinib, an irreversible pan erB receptor tyrosine kinase inhibitor active for advanced HER2+ breast cancer.
| Image |  |
|---|---|
| Description | scientific article published on 23 June 2009 |
| Author/s |
author: Eva M Ciruelos |
| Publication date | June 23, 2009 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |